- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06851000
The Effects of Ultrasound-guided PRF Versus DN in Myofascial Pain Patients
March 4, 2025 updated by: Cui Xulei, Peking Union Medical College Hospital
The Effects of Ultrasound-guided Pulsed Radiofrequemcy Versus Dry Needling in Myofascial Pain Patients
This study aims to compare the effects of pulsed radiofrequency and drying needling and explore the short-term effect of pulsed radiofrequency in treating myofascial pain patients.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jin Wang
- Phone Number: +86 15210424157
- Email: wangjin05@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 18-70 years old, gender unlimited.
- Myofascial pain diagnosed according to the "Simons and Travell" criteria.
- Able to complete treatment and follow-up.
- Signed inform consent form.
Exclusion Criteria:
- History of surgery, trauma, or infection in the pain area.
- Severe systemic disease, e.g. malignant tumor; severe hepatic, renal, or coagulation disorder; etc.
- Pregnancy, needle phobia, unable to cooperate.
- Concurrently receiving pain treatment in other institutions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PRF-PRF
|
Medication: 0-3months; Pulsed radiofrequency: week 2, 6, 10;
|
|
Active Comparator: DN-PRF
|
Medication: 0-3 months; Dry needling: week 2; Pulsed radiofrequency: week 6, 10;
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of mechanical pain threshold (△MPT)
Time Frame: week 0 to week 4
|
Mechanical pain threshold was measured by an ergometer called Microfet3.
△MPT=MPT4wk (MPT measured at week 4)-MPT 2wk (MPT measured at week 2).
|
week 0 to week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of pain
Time Frame: week 0 to week 12
|
Pain was measured by a numerical rating scale (NRS), with 0 symbolizing no pain and 10 symbolizing the worst pain one could imagine.
|
week 0 to week 12
|
|
Sleep
Time Frame: week 0 to week 12
|
The quality of sleep was measured by Athens Insomnia Scale.
|
week 0 to week 12
|
|
Depression and anxiety
Time Frame: week 0 to week 12
|
Depression was measured by Patient Health Questionnaire-9.
Anxiety was measured by a Generalized Anxiety Disorder-7 item scale.
|
week 0 to week 12
|
|
Life quality
Time Frame: week 0 to week 12
|
The quality of life was measured by Short Form 36 Health Survey.
|
week 0 to week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
February 25, 2025
Primary Completion (Estimated)
November 25, 2025
Study Completion (Estimated)
March 25, 2026
Study Registration Dates
First Submitted
February 13, 2025
First Submitted That Met QC Criteria
February 25, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 4, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRF-DN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.